Differential roles of inflammatory cells in pancreatitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 27, Issue SUPPL.2, 2012, Pages 47-51

  Mayerle, Julia ^a   Dummer, Annegret ^a   Sendler, Mathias ^a   Malla, Sudarshan Ravi ^a   van den Brandt, Cindy ^a   Teller, Steffen ^a   Aghdassi, Ali ^a   Nitsche, Claudia ^a   Lerch, Markus M ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

Acute pancreatitis; Antibiotic treatment; Enteral nutrition; Fluid resuscitation; Prognostic factors

Indexed keywords

ANALGESIC AGENT; ANGIOPOIETIN 2; ANTIBIOTIC AGENT; C REACTIVE PROTEIN; PROBIOTIC AGENT; PROCALCITONIN; TRYPSINOGEN; TRYPSINOGEN ACTIVATION PEPTIDE; ZYMOGEN GRANULE;

ACUTE PANCREATITIS; APACHE; ARTICLE; CHOLANGITIS; DISEASE MARKER; DISEASE SEVERITY; ENTERIC FEEDING; FLUID RESUSCITATION; HEMATOCRIT; IMMUNOMODULATION; INFLAMMATORY CELL; PANCREAS NECROSIS; PANCREAS SECRETION; PARENTERAL NUTRITION; PNEUMONIA; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; REHYDRATION; SENSITIVITY AND SPECIFICITY; STOMACH EMPTYING;

EID: 84856951421     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.07011.x     Document Type: Article

References (47)

1. Banks PA. Epidemiology, natural history, and predictors of disease outcome in acute and chronic pancreatitis. Gastrointest. Endosc. 2002; 56: S226-30.
2. Mayerle J, Hlouschek V, Lerch MM. Current management of acute pancreatitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 2005; 2: 473-83.
3. Ellis I, Lerch MM, Whitcomb DC. Genetic testing for hereditary pancreatitis: guidelines for indications, counselling, consent and privacy issues. Pancreatology 2001; 1: 405-15.
4. Howes N, Lerch MM, Greenhalf W etal. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin. Gastroenterol. Hepatol. 2004; 2: 252-61.
5. Mayerle J, Schnekenburger J, Krüger B etal. Extracellular cleavage of E-cadherin by leukocyte elastase during acute experimental pancreatitis in rats. Gastroenterology 2005; 129: 1251-67.
6. Bank S, Singh P, Pooran N, Stark B. Evaluation of factors that have reduced mortality from acute pancreatitis over the past 20years. J. Clin. Gastroenterol. 2002; 35: 50-60.
7. Uhl W, Büchler M, Malfertheiner P, Martini M, Beger HG. PMN-elastase in comparison with CRP, antiproteases, and LDH as indicators of necrosis in human acute pancreatitis. Pancreas 1991; 6: 253-9.
8. Rau BM, Kemppainen EA, Gumbs AA etal. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. Ann. Surg. 2007; 245: 745-54.
9. Buchler M, Malfertheiner P, Schoetensack C, Uhl W, Scherbaum W, Beger HG. Value of biochemical and imaging procedures for the diagnosis and prognosis of acute pancreatitis-results of a prospective clinical study. Z. Gastroenterol. 1986; 24: 100-9.
10. Brown A, Orav J, Banks PA. Hemoconcentration is an early marker for organ failure and necrotizing pancreatitis. Pancreas 2000; 20: 367-72.
11. Lankisch PG, Mahlke R, Blum T etal. Hemoconcentration: an early marker of severe and/or necrotizing pancreatitis? A critical appraisal. Am. J. Gastroenterol. 2001; 96: 2081-5.
12. Hirota M, Takada T, Kitamura N etal. Fundamental and intensive care of acute pancreatitis. J. Hepatobiliary Pancreat. Sci. 2010; 17: 45-52.
13. Neoptolemos JP, Kemppainen EA, Mayer JM etal. Early prediction of severity in acute pancreatitis by urinary trypsinogen activation peptide: a multicentre study. Lancet 2000; 355: 1955-60.
14. Lempinen M, Kylanpaa-Back ML, Stenman UH etal. Predicting the severity of acute pancreatitis by rapid measurement of trypsinogen-2 in urine. Clin. Chem. 2001; 47: 2103-7.
15. Johnson CD, Lempinen M, Imrie CW etal. Urinary trypsinogen activation peptide as a marker of severe acute pancreatitis. Br. J. Surg. 2004; 91: 1027-33.
16. Whitcomb DC, Muddana V, Langmead CJ etal. Angiopoietin-2, a regulator of vascular permeability in inflammation, is associated with persistent organ failure in patients with acute pancreatitis from the United States and Germany. Am. J. Gastroenterol. 2010; 105: 2287-92.
17. Gardner TB, Vege SS, Chari ST etal. Faster rate of initial fluid resuscitation in severe acute pancreatitis diminishes in-hospital mortality. Pancreatology 2009; 9: 770-6.
18. Wu BU, Conwell DL, Singh VK etal. Early hemoconcentration is associated with pancreatic necrosis only among transferred patients. Pancreas 2009; 39: 572-6.
19. Wu BU, Johannes RS, Sun X, Conwell DL, Banks PA. Early changes in blood urea nitrogen predict mortality in acute pancreatitis. Gastroenterology 2009; 137: 129-35.
20. Brown A, Baillargeon JD, Hughes MD, Banks PA. Can fluid resuscitation prevent pancreatic necrosis in severe acute pancreatitis? Pancreatology 2002; 2: 104-7.
21. Mao EQ, Tang YQ, Fei J etal. Fluid therapy for severe acute pancreatitis in acute response stage. Chin. Med. J. (Engl.) 2009; 122: 169-73.
22. Brunkhorst FM, Engel C, Bloos F etal. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N. Engl. J. Med. 2008; 358: 125-39.
23. UK guidelines for the management of acute pancreatitis. Gut 2005; 54 (Suppl. 3): iii1-9.
24. Thompson DR. Narcotic analgesic effects on the sphincter of Oddi: a review of the data and therapeutic implications in treating pancreatitis. Am. J. Gastroenterol. 2001; 96: 1266-72.
25. Bernhardt A, Kortgen A, Niesel H, Goertz A. Using epidural anesthesia in patients with acute pancreatitis-prospective study of 121 patients. Anaesthesiol. Reanim. 2002; 27: 16-22.
26. Beger HG, Bittner R, Block S, Buchler M. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology 1986; 91: 433-8.
27. Golub R, Siddiqi F, Pohl D. Role of antibiotics in acute pancreatitis: a meta-analysis. J. Gastrointest. Surg. 1998; 2: 496-503.
28. Dellinger EP, Tellado JM, Soto NE etal. Early antibiotic treatment for severe acute necrotizing pancreatitis: a randomized, double-blind, placebo-controlled study. Ann. Surg. 2007; 245: 674-83.
29. Isenmann R, Runzi M, Kron M etal. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: a placebo-controlled, double-blind trial. Gastroenterology 2004; 126: 997-1004.
30. de Vries AC, Besselink MG, Buskens E etal. Randomized controlled trials of antibiotic prophylaxis in severe acute pancreatitis: relationship between methodological quality and outcome. Pancreatology 2007; 7: 531-8.
31. Farkas G, Marton J, Mandi Y, Szederkenyi E, Balogh A. Progress in the management and treatment of infected pancreatic necrosis. Scand. J. Gastroenterol. Suppl. 1998; 228: 31-7.
32. Olah A, Belagyi T, Issekutz A, Olgyai G. Combination of early nasojejunal feeding with modern synbiotic therapy in the treatment of severe acute pancreatitis (prospective, randomized, double-blind study). Magy. Seb. 2005; 58: 173-8.
33. Besselink MG, van Santvoort HC, Buskens E etal. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371: 651-9.
34. Sand J, Nordback I. Probiotics in severe acute pancreatitis. Lancet 2008; 371: 634-5.
35. Eatock FC, Brombacher GD, Steven A, Imrie CW, McKay CJ, Carter R. Nasogastric feeding in severe acute pancreatitis may be practical and safe. Int. J. Pancreatol. 2000; 28: 23-9.
36. Kumar A, Singh N, Prakash S, Saraya A, Joshi YK. Early enteral nutrition in severe acute pancreatitis: a prospective randomized controlled trial comparing nasojejunal and nasogastric routes. J. Clin. Gastroenterol. 2006; 40: 431-4.
37. Lecleire S, Antonietti M, Ben-Soussan E etal. Nasojejunal feeding in patients with severe acute pancreatitis: comparison of endoscopic and self-migration tube placement. Pancreas 2007; 35: 376-8.
38. Singh N, Sharma B, Sharma M etal. Evaluation of early enteral feeding through nasogastric and nasojejunal tube in severe acute pancreatitis: a noninferiority randomized controlled trial. Pancreas 14 July 2011 [Epub ahead of print].
39. Pezzilli R, Miglioli M. Multicentre comparative study of two schedules of gabexate mesilate in the treatment of acute pancreatitis. Italian Acute Pancreatitis Study Group. Dig. Liver Dis. 2001; 33: 49-57.
40. Büchler M, Malfertheiner P, Uhl W etal. Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group. Gastroenterology 1993; 104: 1165-70.
41. Frossard JL, Saluja A, Bhagat L etal. The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology 1999; 116: 694-701.
42. Sandoval D, Gukovskaya A, Reavey P etal. The role of neutrophils and platelet-activating factor in mediating experimental pancreatitis. Gastroenterology 1996; 111: 1081-91.
43. Devière J, Le Moine O, Van Laethem JL etal. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography. Gastroenterology 2001; 120: 498-505.
44. Lankisch PG, Lerch MM. Pharmacological prevention and treatment of acute pancreatitis: where are we now? Dig. Dis. 2006; 24: 148-59.
45. Andriulli A, Leandro G, Federici T etal. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis. Gastrointest. Endosc. 2007; 65: 624-32.
46. Cavallini G, Tittobello A, Frulloni L, Masci E, Mariana A, Di Francesco V. Gabexate for the prevention of pancreatic damage related endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy-Italian Group. N. Engl. J. Med. 1996; P335: 919-23.
47. Johnson CD, Kingsnorth AN, Imrie CW etal. Double blind, randomised, placebo controlled study of a platelet activating factor antagonist, lexipafant, in the treatment and prevention of organ failure in predicted severe acute pancreatitis. Gut 2001; 48: 62-9.